Shamin Rezaei

616 total citations
8 papers, 319 citations indexed

About

Shamin Rezaei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shamin Rezaei has authored 8 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Shamin Rezaei's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). Shamin Rezaei is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). Shamin Rezaei collaborates with scholars based in Iran, Spain and United States. Shamin Rezaei's co-authors include Afshin Taheriazam, Mehrdad Hashemi, Maliheh Entezari, Amirabbas Kakavand, Shokooh Salimimoghadam, Saeed Samarghandian, Elahe Sadat Hejazi, Hamidreza Saebfar, Sima Orouei and Mehrdokht Sadrkhanloo and has published in prestigious journals such as Pharmacological Research, Biomedicine & Pharmacotherapy and Current Cancer Drug Targets.

In The Last Decade

Shamin Rezaei

8 papers receiving 317 citations

Peers

Shamin Rezaei

MB

CR

ONCOL

PRM

IMMUN

Elahe Sadat Hejazi Iran

Zhigang Cao China

Jianjun Xu China

Ramiro J. Vicente-Blanco Spain

Binbin Cui China

Rendy Hosea China

Lin Shi China

Yunfei Yan China

Sara Laine-Menéndez Spain

Faying Xu China

Elahe Sadat Hejazi Iran

Shamin Rezaei

217 ×1.0

MB

150 ×0.9

CR

68 ×0.9

ONCOL

46 ×0.9

PRM

31 ×0.9

IMMUN

Citations per year, relative to Shamin Rezaei Shamin Rezaei (= 1×) peers Elahe Sadat Hejazi

Countries citing papers authored by Shamin Rezaei

Since Specialization

Citations

This map shows the geographic impact of Shamin Rezaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shamin Rezaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shamin Rezaei more than expected).

Fields of papers citing papers by Shamin Rezaei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shamin Rezaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shamin Rezaei. The network helps show where Shamin Rezaei may publish in the future.

Co-authorship network of co-authors of Shamin Rezaei

This figure shows the co-authorship network connecting the top 25 collaborators of Shamin Rezaei. A scholar is included among the top collaborators of Shamin Rezaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shamin Rezaei. Shamin Rezaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.. (2023). miRNAs as short non-coding RNAs in regulating doxorubicin resistance. Journal of Cell Communication and Signaling. 17(4). 1181–1202. 2 indexed citations

2.

Entezari, Maliheh, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.. (2023). Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance. Current Cancer Drug Targets. 24(1). 94–113. 3 indexed citations

3.

Sadrkhanloo, Mehrdokht, Maliheh Entezari, Sima Orouei, et al.. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research. 182. 106311–106311. 114 indexed citations

4.

Hashemi, Mehrdad, Chakrabhavi Dhananjaya Mohan, Shamin Rezaei, et al.. (2022). Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance. Pharmacological Research. 186. 106535–106535. 31 indexed citations

5.

Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.. (2022). SOX2 function in cancers: Association with growth, invasion, stemness and therapy response. Biomedicine & Pharmacotherapy. 156. 113860–113860. 38 indexed citations

6.

Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.. (2022). siRNA and targeted delivery systems in breast cancer therapy. Clinical & Translational Oncology. 25(5). 1167–1188. 12 indexed citations

7.

Hashemi, Mehrdad, Afshin Taheriazam, Amirabbas Kakavand, et al.. (2022). Targeting PI3K/Akt signaling in prostate cancer therapy. Journal of Cell Communication and Signaling. 17(3). 423–443. 58 indexed citations

8.

Entezari, Maliheh, Afshin Taheriazam, Sima Orouei, et al.. (2022). LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy. 154. 113609–113609. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact